Generali Asset Management SPA SGR Sells 71,604 Shares of Amrize Ltd $AMRZ

Generali Asset Management SPA SGR cut its position in Amrize Ltd (NYSE:AMRZ) by 92.2% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 6,026 shares of the company’s stock after selling 71,604 shares during the quarter. Generali Asset Management SPA SGR’s holdings in Amrize were worth $225,000 at the end of the most recent reporting period.

Several other institutional investors have also recently bought and sold shares of AMRZ. Amundi boosted its holdings in Amrize by 30.9% during the first quarter. Amundi now owns 1,654,739 shares of the company’s stock valued at $92,698,000 after acquiring an additional 390,750 shares during the period. DJE Kapital AG grew its position in shares of Amrize by 45.9% in the first quarter. DJE Kapital AG now owns 1,113,036 shares of the company’s stock valued at $60,194,000 after purchasing an additional 350,149 shares during the last quarter. Great Lakes Advisors LLC bought a new position in shares of Amrize in the second quarter worth about $16,975,000. Ancora Advisors LLC bought a new position in shares of Amrize in the second quarter worth about $15,112,000. Finally, Assetmark Inc. increased its stake in shares of Amrize by 18,567.2% in the first quarter. Assetmark Inc. now owns 250,887 shares of the company’s stock worth $14,055,000 after purchasing an additional 249,543 shares during the period.

Wall Street Analyst Weigh In

Several brokerages recently weighed in on AMRZ. Barclays decreased their target price on Amrize from $55.00 to $40.00 and set an “equal weight” rating for the company in a research note on Monday, October 19th. Truist Financial lowered their target price on Amrize from $48.00 to $35.00 and set a “hold” rating on the stock in a report on Monday, October 5th. JPMorgan Chase & Co. dropped their price target on Amrize from $52.00 to $48.00 and set a “neutral” rating on the stock in a research report on Tuesday, October 13th. Stephens cut their price target on Amrize from $65.00 to $54.00 and set an “overweight” rating for the company in a report on Wednesday, August 12th. Finally, Oppenheimer reduced their price objective on Amrize from $62.00 to $55.00 and set an “outperform” rating for the company in a research report on Friday, September 18th. Eight investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and four have issued a Sell rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $49.24.

Amrize Stock Performance

NYSE AMRZ opened at $41.40 on Friday. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.10 and a quick ratio of 0.73. The firm has a market capitalization of $22.90 billion, a price-to-earnings ratio of 18.73, a P/E/G ratio of 1.49 and a beta of 0.20. The company’s fifty day moving average is $39.73 and its two-hundred day moving average is $50.59. Amrize Ltd has a 52-week low of $35.78 and a 52-week high of $65.94.

Amrize (NYSE:AMRZ) last posted its quarterly earnings data on Wednesday, October 28th. The company reported $1.05 earnings per share (EPS) for the quarter, hitting the consensus estimate of $1.05. The company had revenue of $3.77 billion for the quarter. Amrize had a net margin of 9.93% and a return on equity of 9.96%. The business’s revenue for the quarter was up 2.6% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.98 EPS. Equities research analysts forecast that Amrize Ltd will post 2.41 EPS for the current year.

Amrize Announces Dividend

The company also recently announced a dividend, which will be paid on Wednesday, November 18th. Investors of record on Tuesday, November 10th will be given a dividend of $0.11 per share. The ex-dividend date of this dividend is Tuesday, November 10th. Amrize’s dividend payout ratio (DPR) is 4.98%.

Insider Buying and Selling at Amrize

In other news, CEO Jan Jenisch purchased 4,000 shares of the stock in a transaction that occurred on Wednesday, September 2nd. The shares were purchased at an average cost of $42.50 per share, for a total transaction of $170,000.00. Following the completion of the purchase, the chief executive officer directly owned 519,000 shares of the company’s stock, valued at approximately $22,057,500. The trade was a 0.78% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Jaime Hill purchased 1,500 shares of the stock in a transaction that occurred on Tuesday, August 11th. The shares were purchased at an average price of $47.12 per share, for a total transaction of $70,680.00. Following the completion of the purchase, the insider directly owned 29,698 shares of the company’s stock, valued at approximately $1,399,369.76. This trade represents a 5.32% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders acquired 48,983 shares of company stock valued at $2,158,755 over the last quarter. Company insiders own 0.54% of the company’s stock.

Key Headlines Impacting Amrize

Here are the key news stories impacting Amrize this week:

• Positive Sentiment: Third-quarter earnings exceeded some estimates. Amrize reported quarterly adjusted earnings of approximately $1.02 per share, above the $0.98 consensus estimate, while net income rose 3.3% year over year to $558 million. Revenue increased roughly 2.2%-2.6% to $3.77 billion. Amrize Q3 Earnings Surpass Estimates
• Positive Sentiment: Pricing remained a key strength. Aggregates pricing increased 6.9% and cement pricing rose 1.8%, helping offset inflationary pressures and support profitability. Amrize: 3 Key Takeaways for Long-Term Investors
• Positive Sentiment: Shareholder returns received support. Amrize completed its $1 billion share-repurchase program and plans to cancel the repurchased shares, which could reduce the share count. It also declared a quarterly dividend of $0.11 per share, payable November 18 to eligible shareholders. Amrize Completes $1 Billion Share Repurchase Program
• Neutral Sentiment: Results were broadly resilient but not uniformly strong. EPS matched the company’s reported consensus estimate of $1.05 in one earnings report, while adjusted earnings were described as flat year over year, highlighting limited underlying earnings growth.
• Negative Sentiment: Full-year revenue guidance was reduced relative to expectations. Amrize now expects 2026 revenue of $12.2 billion-$12.4 billion, below the roughly $12.5 billion analyst consensus, signaling softer demand or greater operating pressure than anticipated.
• Negative Sentiment: Wells Fargo cut its price target from $40 to $39 and maintained an “equal weight” rating. The revision indicates limited near-term upside in the bank’s view and adds to the cautious outlook surrounding AMRZ.

Amrize Company Profile

Amrize is a North American building-solutions company that supplies materials and products used in residential, commercial and infrastructure construction. Its portfolio includes cement, aggregates, ready-mix concrete, asphalt, roofing systems and other building products.

The company serves customers across the United States and Canada through a network of production facilities, distribution locations and related operations. Its products support applications ranging from roads, bridges and other public infrastructure to commercial buildings and residential construction.

Amrize was formed through the separation of Holcim’s North American business and began trading independently on the New York Stock Exchange under the symbol AMRZ in 2025.